Menlo Park, CA
Hexagon Bio is a data-driven biotech developing targeted small molecule therapeutics. Our proprietary platform combines data science and synthetic biology to discover and engineer drugs from DNA sequences. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.
hexagonbio.comThese are collections Hexagon Bio is a part of. Click on the collection name to view similar companies.
Series B
$77,300,000
Series Unknown
$61,000,001
Series A
$47,000,000
Seed
$8,300,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Hexagon Bio.